Ginkgo Bioworks Holdings (NYSE:DNA) is preparing to release its quarterly earnings on Thursday, 2026-02-26. Here's a brief overview of what investors should keep in mind before the announcement.
Ginkgo Bioworks reported Q4 revenues of $33 million, down 24% year-over-year, and missing estimates by over $4 million. Cell Engineering, expected to drive growth, delivered just $125 million in 2025 ...
Ginkgo Bioworks Holdings (NYSE: DNA) shares are trading higher Monday afternoon, up over 8%, following the announcement of a strategic partnership with Carnegie Mellon University under the Advanced ...
About Ginkgo Bioworks Holdings Inc. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial ...
Jason Kelly, chief executive of Ginkgo Bioworks, spent a surprising amount of time on an earnings call with analysts last week talking about transportation, riding subways, and self-driving cars. “If ...
Hosted on MSN
Ginkgo Bioworks Holdings, Inc. (DNA) falls more steeply than broader market: What investors need to know
Ginkgo Bioworks Holdings, Inc. (DNA) closed the most recent trading day at $9.23, moving -9.06% from the previous trading session. This move lagged the S&P 500's daily loss of 0.33%. At the same time, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results